Cortechs.ai and ALZ-NET Collaborate on AI-Driven Alzheimer's Care

Cortechs.ai has announced a strategic collaboration with ALZ-NET to improve Alzheimer's disease care through AI-driven imaging, announced in a press release. This partnership aims to enhance clinical decision-making and care delivery by integrating Cortechs.ai's NeuroQuant® for ARIA imaging platform with ALZ-NET's real-world data network.

NeuroQuant® for ARIA provides precise segmentation, quantification, and tracking of lesions, aiding in the surveillance of amyloid-related imaging abnormalities in patients undergoing anti-amyloid therapies. The collaboration will offer discounted access to this platform for ALZ-NET sites, facilitating improved monitoring and treatment practices.

Dr. Ana Franceschi, a member of both the Cortechs.ai Medical Advisory Board and ALZ-NET's Imaging Work Group, emphasized the importance of combining advanced neuroimaging analytics with real-world data to optimize safety and monitoring for Alzheimer's patients. This initiative is supported by the Alzheimer's Association and managed by the American College of Radiology, aiming to provide evidence-based insights into the long-term safety and efficacy of Alzheimer's therapies.